Quarterly Result27 Apr 2026, 08:43 pm
Aptus Pharma: FY26 Audited Results Approved; Bonus 3:2 Set
AI Summary
Aptus Pharma Ltd's Board of Directors approved the audited financial results for the half year and full financial year ended March 31, 2026, with an unmodified audit opinion. Additionally, the company announced a bonus share issue in the ratio of 3:2 (three equity shares for every two existing shares). The record date for determining eligible shareholders for the bonus shares has been fixed as Tuesday, May 12, 2026.
Key Highlights
- Board approved audited financial results for FY26.
- Auditors issued an unmodified opinion on FY26 results.
- Bonus shares approved in 3:2 ratio.
- Record date for bonus shares set for May 12, 2026.